Maziar Bidar, MD
Ophthalmology · Monterey
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 27 years
- George Washington University School of Medicine, 1999
Offices
1 location · Vantage Eye Center A Medical Corp · 19 clinicians in this group
Hospitals listed: Community Hospital of the Monterey Peninsula · Salinas Valley Health Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bidar’s office at (831) 373-7733 to ask if they take your plan before you enroll.
California Medical Board record
Licence A86968 · Current
Licensed to practise in California · since 2004 · expires 2028-05-31 · George Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Summit SurgicalAmbulatory Surgery Center · Fresno, CA.9 owner since 2010 · accredited by AAAHCAccreditation Renewed1 inspection, 1 with deficiencies · last 2017-05-08: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Ophthalmology - Ophthalmology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- Salinas Valley Health Medical CenterSalinas, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Salinas Valley Memorial Healthcare SystemPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Salinas Valley Health Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.34 to 2.3) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.68 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.42 (143.23 to 253.6) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (1.83 to 6.1) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.87 to 3.76) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (3.73 to 15.83) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.23 (1.52 to 8.95) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,011 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.487 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.082 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.432 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8 · 660 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 569 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 485 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.2 to 8.4) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 489 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$345,339
Medicare paid this office $345,339 for 928 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Repair of tendon of upper eyelid | 129 | $85,265 | $656 |
| Removal of excessive skin and fat of upper eyelid | 64 | $40,496 | $633 |
| Return visit (30+ min) | 313 | $30,868 | $96 |
| Short return visit (20+ min) | 307 | $20,847 | $60 |
| Injection, incobotulinumtoxin a, 1 unit | 31 | $20,515 | None |
See all 20 services
| Repair of tendon of upper eyelid | 129 | $85,265 | $656 |
| Removal of excessive skin and fat of upper eyelid | 64 | $40,496 | $633 |
| Return visit (30+ min) | 313 | $30,868 | $96 |
| Short return visit (20+ min) | 307 | $20,847 | $60 |
| Injection, incobotulinumtoxin a, 1 unit | 31 | $20,515 | None |
| New patient visit (45+ min) | 184 | $19,117 | $104 |
| Insertion of probe into nasal tear duct | 88 | $14,429 | $149 |
| Removal of growth of eyelid | 57 | $11,849 | $201 |
| Repair of tendon of upper eyelid | 13 | $10,785 | $830 |
| Creation of flap graft to midface | 13 | $8,054 | $620 |
| Face injection for nerve paralysis | 37 | $7,272 | $102 |
| Repair of brow paralysis | 22 | $6,247 | $284 |
| Photography of content of eyes | 302 | $4,861 | $16 |
| Reconstruction of eyelid margin | 15 | $4,516 | $301 |
| New patient complete exam of visual system | 17 | $2,076 | $122 |
| Snip incision of tear duct at inner corner of eye | 19 | $1,635 | $78 |
| Injection into skin growth, 1-7 growths | 21 | $947 | $43 |
| New patient visit (30+ min) | 12 | $937 | $78 |
| Snip incision of tear duct at inner corner of eye | 16 | $834 | $52 |
| Removal of eyelashes using forceps | 12 | $166 | $10 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Face injection for nerve paralysis | 121 | 131 | 149 | 191 | 160 | 71 |
| Repair of tendon of upper eyelid | 125 | 84 | 84 | 98 | 158 | 143 |
| Dilation of tear drainage opening | 138 | 107 | 113 | 112 | 20 | – |
| Removal of growth of eyelid | 46 | 48 | 61 | 69 | 68 | 59 |
| Removal of excessive skin and fat of upper eyelid | 46 | 60 | 30 | 55 | 87 | 64 |
| Insertion of probe into nasal tear duct | – | – | – | – | 133 | 97 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
928 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 11% · Women 65% · Also on Medicaid 26% · Health risk score 1.08. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 35% · Coronary heart disease 28% · Chronic kidney disease 22% · Depression 19% · Heart failure 14% · Atrial fibrillation 14% · Cancer 13% · COPD 11% · Stroke 7% · Dementia 4%.
The office billed $1,387,927, Medicare allowed $461,157 and paid $345,339; for 8,111 services of 64 kinds; $25,376 of it was for drugs given in the office and $319,964 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 928 | 8,111 | 75 | 1.08 | $1,387,927 | $345,339 |
| 2023 | 962 | 17,300 | 74 | 1.03 | $2,082,898 | $514,184 |
| 2022 | 801 | 20,002 | 75 | 0.97 | $1,576,952 | $408,272 |
| 2021 | 716 | 16,717 | 74 | 0.95 | $1,297,316 | $372,185 |
| 2020 | 698 | 15,175 | 74 | 1.01 | $1,954,123 | $349,111 |
| 2019 | 812 | 13,983 | 75 | 1.07 | $1,490,119 | $401,164 |
| 2018 | 780 | 11,421 | 74 | 1.10 | $1,254,889 | $315,161 |
| 2017 | 849 | 9,616 | 75 | 1.15 | $1,478,636 | $358,126 |
| 2016 | 848 | 7,500 | 75 | 1.07 | $1,578,437 | $378,791 |
| 2015 | 782 | 7,448 | 75 | 1.14 | $1,370,813 | $346,003 |
| 2014 | 754 | 6,600 | 75 | 1.10 | $1,549,037 | $377,361 |
| 2013 | 817 | 5,528 | 75 | 1.14 | $1,363,756 | $387,973 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 29 services
| Repair of tendon of upper eyelid | 144 | $99,337 | $690 |
| Removal of excessive skin and fat of upper eyelid | 87 | $57,539 | $661 |
| Injection, incobotulinumtoxin a, 1 unit | 57 | $48,980 | None |
| Short return visit (20+ min) | 563 | $46,278 | $65 |
| Insertion of probe into nasal tear duct | 104 | $21,558 | $162 |
| Face injection for nerve paralysis | 66 | $19,357 | $121 |
| New patient visit (45+ min) | 157 | $19,204 | $122 |
| Return visit (30+ min) | 180 | $18,578 | $98 |
| Creation of flap graft to midface | 26 | $17,235 | $638 |
| Removal of growth of eyelid | 54 | $13,608 | $239 |
| Botox | 12 | $10,959 | None |
| Photography of content of eyes | 558 | $10,845 | $18 |
| Repair of tendon of upper eyelid | 14 | $10,720 | $766 |
| Repair of brow paralysis | 34 | $9,769 | $287 |
| Reconstruction of eyelid margin | 29 | $9,608 | $320 |
| Removal of over 1/4 of eyelid margin and repair of eyelid | 21 | $8,902 | $424 |
| Correction of widely-opened upper eyelid | 13 | $5,703 | $407 |
| Reconstruction of eyelid margin | 12 | $5,011 | $418 |
| Repair of eyelid lining with graft from external eye | 14 | $3,769 | $269 |
| Snip incision of tear duct at inner corner of eye | 32 | $3,135 | $82 |
| New patient visit (30+ min) | 39 | $2,506 | $64 |
| Suture repair of turning-inward eyelid defect | 12 | $1,665 | $139 |
| Dilation of tear drainage opening | 19 | $1,372 | $69 |
| Probing of nasal tear duct with insertion of tube or stent | 12 | $1,275 | $98 |
| Removal of growth of eyelid | 11 | $901 | $82 |
| Snip incision of tear duct at inner corner of eye | 12 | $766 | $59 |
| Injection into skin growth, 1-7 growths | 12 | $589 | $42 |
| Removal of eyelashes using forceps | 15 | $314 | $15 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $12 | None |
2022: 25 services
| Repair of tendon of upper eyelid | 83 | $58,245 | $693 |
| Injection, incobotulinumtoxin a, 1 unit | 60 | $46,960 | None |
| Short return visit (20+ min) | 455 | $41,160 | $67 |
| Botox | 22 | $26,050 | None |
| Face injection for nerve paralysis | 72 | $25,089 | $131 |
| Removal of excessive skin and fat of upper eyelid | 40 | $24,494 | $612 |
| Removal of growth of eyelid | 65 | $15,891 | $230 |
| Return visit (30+ min) | 130 | $12,464 | $87 |
| Repair of tendon of upper eyelid | 14 | $11,926 | $852 |
| Photography of content of eyes | 567 | $11,344 | $18 |
| Creation of flap graft to midface | 16 | $10,885 | $680 |
| Removal of excessive skin and fat of upper eyelid | 15 | $10,826 | $722 |
| New patient visit (45+ min) | 85 | $9,979 | $117 |
| Reconstruction of eyelid margin | 29 | $9,800 | $338 |
| Dilation of tear drainage opening | 83 | $9,543 | $85 |
| Correction of widely-opened upper eyelid | 18 | $7,420 | $412 |
| New patient visit (30+ min) | 59 | $4,959 | $84 |
| Repair of brow paralysis | 11 | $3,310 | $301 |
| Repair of eyelid lining with graft from external eye | 12 | $3,249 | $271 |
| Probing of nasal tear duct | 12 | $1,838 | $141 |
| Suture repair of turning-outward upper or lower eyelid defect | 11 | $1,818 | $165 |
| Established patient problem focused exam of visual system | 30 | $1,574 | $48 |
| Snip incision of tear duct at inner corner of eye | 17 | $887 | $52 |
| Exam of visual field with limited testing | 29 | $587 | $20 |
| Removal of eyelashes using forceps | 21 | $379 | $13 |
2021: 22 services
| Repair of tendon of upper eyelid | 64 | $46,084 | $720 |
| Injection, incobotulinumtoxin a, 1 unit | 32 | $33,291 | None |
| Short return visit (20+ min) | 318 | $30,769 | $67 |
| Botox | 24 | $25,154 | None |
| Return visit (30+ min) | 176 | $20,860 | $102 |
| Face injection for nerve paralysis | 49 | $18,951 | $127 |
| Removal of excessive skin and fat of upper eyelid | 30 | $18,736 | $625 |
| Repair of tendon of upper eyelid | 20 | $16,778 | $839 |
| Removal of growth of eyelid | 54 | $14,627 | $240 |
| Photography of content of eyes | 521 | $11,309 | $18 |
| Dilation of tear drainage opening | 66 | $9,605 | $85 |
| New patient visit (45+ min) | 70 | $9,110 | $130 |
| Established patient problem focused exam of visual system | 105 | $9,047 | $65 |
| Reconstruction of eyelid margin | 22 | $6,087 | $277 |
| Probing of nasal tear duct | 26 | $3,974 | $132 |
| Exam of visual field with limited testing | 109 | $2,642 | $24 |
| New patient visit (30+ min) | 38 | $2,617 | $69 |
| Exam of visual field with intermediate testing | 59 | $2,329 | $39 |
| Established patient complete exam of visual system | 24 | $2,173 | $91 |
| New patient complete exam of visual system | 16 | $1,688 | $105 |
| Removal of eyelashes | 12 | $1,538 | $96 |
| Removal of eyelashes using forceps | 27 | $647 | $15 |
2020: 24 services
| Repair of tendon of upper eyelid | 83 | $58,682 | $699 |
| Removal of excessive skin and fat of upper eyelid | 60 | $40,250 | $671 |
| Established patient problem focused exam of visual system | 381 | $32,703 | $68 |
| Injection, incobotulinumtoxin a, 1 unit | 34 | $30,904 | None |
| Botox | 30 | $21,320 | None |
| Face injection for nerve paralysis | 56 | $15,469 | $118 |
| Short return visit (20+ min) | 172 | $11,053 | $57 |
| Removal of growth of eyelid | 42 | $10,515 | $219 |
| Reconstruction of eyelid margin | 23 | $9,303 | $404 |
| Return visit (30+ min) | 78 | $8,714 | $79 |
| Dilation of tear drainage opening | 66 | $8,090 | $76 |
| Photography of content of eyes | 375 | $7,708 | $18 |
| New patient visit (30+ min) | 56 | $4,632 | $83 |
| Probing of nasal tear duct | 27 | $3,797 | $136 |
| Established patient complete exam of visual system | 27 | $2,902 | $104 |
| Suture repair of turning-outward upper or lower eyelid defect | 12 | $2,103 | $175 |
| New patient complete exam of visual system | 17 | $1,917 | $113 |
| Exam of visual field with limited testing | 76 | $1,807 | $24 |
| Removal of chronic growth of eyelid | 11 | $1,034 | $94 |
| Injection of drug into eye | 11 | $930 | $85 |
| Exam of visual field with intermediate testing | 16 | $660 | $41 |
| Snip incision of tear duct at inner corner of eye | 12 | $616 | $51 |
| Imaging of retina | 15 | $449 | $30 |
| Removal of eyelashes using forceps | 21 | $444 | $17 |
2019: 24 services
| Repair of tendon of upper eyelid | 112 | $78,171 | $692 |
| Established patient problem focused exam of visual system | 368 | $32,355 | $67 |
| Removal of excessive skin and fat of upper eyelid | 46 | $30,983 | $674 |
| Injection, incobotulinumtoxin a, 1 unit | 27 | $24,498 | None |
| Short return visit (20+ min) | 307 | $21,351 | $56 |
| Botox | 23 | $17,817 | None |
| Reconstruction of eyelid margin | 42 | $17,641 | $392 |
| Face injection for nerve paralysis | 47 | $15,777 | $130 |
| Dilation of tear drainage opening | 97 | $11,530 | $84 |
| Removal of growth of eyelid | 44 | $10,591 | $230 |
| Return visit (30+ min) | 88 | $10,158 | $90 |
| Repair of tendon of upper eyelid | 12 | $10,036 | $836 |
| Photography of content of eyes | 484 | $9,745 | $17 |
| New patient visit (30+ min) | 100 | $8,027 | $80 |
| Exam of visual field with intermediate testing | 131 | $4,957 | $38 |
| Suture repair of turning-outward upper or lower eyelid defect | 25 | $4,711 | $181 |
| Repair of eyelid lining with graft from external eye | 13 | $4,443 | $278 |
| Probing of nasal tear duct | 21 | $3,488 | $152 |
| Suture repair of turning-inward eyelid defect | 15 | $2,695 | $168 |
| Exam of visual field with limited testing | 84 | $2,034 | $24 |
| Removal of eyelashes | 13 | $1,369 | $91 |
| Removal of chronic growth of eyelid | 11 | $1,147 | $88 |
| Snip incision of tear duct at inner corner of eye | 18 | $1,075 | $57 |
| Removal of eyelashes using forceps | 24 | $785 | $25 |
2018: 19 services
| Repair of tendon of upper eyelid | 94 | $62,090 | $654 |
| Removal of excessive skin and fat of upper eyelid | 57 | $36,732 | $644 |
| Established patient problem focused exam of visual system | 327 | $27,261 | $69 |
| Short return visit (20+ min) | 384 | $24,001 | $51 |
| Injection, incobotulinumtoxin a, 1 unit | 23 | $19,082 | None |
| Botox | 23 | $13,944 | None |
| Dilation of tear drainage opening | 105 | $13,544 | $84 |
| Face injection for nerve paralysis | 37 | $13,531 | $121 |
| Reconstruction of eyelid margin | 25 | $9,643 | $371 |
| New patient visit (30+ min) | 129 | $9,123 | $71 |
| Removal of growth of eyelid | 41 | $9,068 | $206 |
| Photography of content of eyes | 404 | $7,194 | $15 |
| Exam of visual field with intermediate testing | 134 | $4,965 | $36 |
| Repair of brow paralysis | 15 | $4,465 | $298 |
| Return visit (30+ min) | 47 | $3,982 | $83 |
| Removal of eyelashes | 16 | $1,878 | $110 |
| Suture repair of turning-inward eyelid defect | 12 | $1,667 | $139 |
| Removal of eyelashes using forceps | 33 | $1,591 | $32 |
| Short return visit | 16 | $465 | $29 |
2017: 21 services
| Repair of tendon of upper eyelid | 117 | $80,335 | $681 |
| Removal of excessive skin and fat of upper eyelid | 60 | $39,202 | $653 |
| Short return visit (20+ min) | 512 | $36,631 | $53 |
| Dilation of tear drainage opening | 133 | $17,828 | $85 |
| Injection, incobotulinumtoxin a, 1 unit | 32 | $15,869 | None |
| Reconstruction of eyelid margin | 42 | $15,737 | $366 |
| Established patient problem focused exam of visual system | 202 | $14,451 | $59 |
| Face injection for nerve paralysis | 41 | $13,177 | $120 |
| Removal of growth of eyelid | 58 | $12,814 | $217 |
| Injection, abobotulinumtoxina, 5 units | 20 | $11,515 | None |
| New patient visit (30+ min) | 149 | $11,412 | $77 |
| Photography of content of eyes | 437 | $7,825 | $15 |
| Exam of visual field with intermediate testing | 167 | $6,252 | $37 |
| Return visit (30+ min) | 44 | $4,692 | $82 |
| Suture repair of turning-outward upper or lower eyelid defect | 23 | $3,930 | $171 |
| Removal of eyelashes using forceps | 32 | $1,648 | $39 |
| Removal of eyelashes | 13 | $1,412 | $88 |
| Snip incision of tear duct at inner corner of eye | 13 | $1,201 | $92 |
| Short return visit | 28 | $1,045 | $36 |
| Removal of growth of eyelid | 13 | $1,015 | $78 |
| Snip incision of tear duct at inner corner of eye | 16 | $845 | $53 |
2016: 27 services
| Repair of tendon of upper eyelid | 96 | $66,045 | $681 |
| Removal of excessive skin and fat of upper eyelid | 85 | $54,932 | $646 |
| Established patient problem focused exam of visual system | 367 | $30,083 | $64 |
| Short return visit (20+ min) | 366 | $22,880 | $52 |
| Removal of growth of eyelid | 86 | $20,575 | $229 |
| Reconstruction of eyelid margin | 58 | $20,430 | $352 |
| Dilation of tear drainage opening | 128 | $16,075 | $95 |
| Muscle flap wound repair at head and neck | 12 | $11,578 | $827 |
| New patient visit (30+ min) | 147 | $10,491 | $71 |
| Injection, incobotulinumtoxin a, 1 unit | 20 | $10,138 | None |
| Face injection for nerve paralysis | 33 | $8,910 | $116 |
| Photography of content of eyes | 455 | $7,753 | $15 |
| Injection, abobotulinumtoxina, 5 units | 18 | $7,304 | None |
| Exam of visual field with intermediate testing | 187 | $6,861 | $36 |
| Incision of tear duct using an endoscope | 11 | $6,110 | $509 |
| Removal of over 1/4 of eyelid margin and repair of eyelid | 11 | $5,136 | $467 |
| Repair of brow paralysis | 17 | $4,914 | $289 |
| Suture repair of turning-outward upper or lower eyelid defect | 22 | $3,478 | $158 |
| Return visit (30+ min) | 29 | $2,745 | $78 |
| Suture repair of turning-inward eyelid defect | 16 | $2,582 | $161 |
| New patient visit (45+ min) | 17 | $1,908 | $112 |
| Established patient complete exam of visual system | 15 | $1,803 | $95 |
| Snip incision of tear duct at inner corner of eye | 24 | $1,183 | $49 |
| Removal of eyelashes using forceps | 22 | $1,124 | $40 |
| Probing of nasal tear duct with insertion of tube or stent | 11 | $1,105 | $92 |
| Removal of eyelashes | 11 | $852 | $71 |
| Exam of visual field with limited testing | 12 | $233 | $19 |
2015: 24 services
| Removal of excessive skin and fat of upper eyelid | 100 | $64,946 | $649 |
| Repair of tendon of upper eyelid | 73 | $50,105 | $686 |
| Short return visit (20+ min) | 466 | $31,846 | $55 |
| Dilation of tear drainage opening | 141 | $25,571 | $131 |
| Reconstruction of eyelid margin | 53 | $21,272 | $401 |
| Botox | 32 | $20,361 | None |
| Established patient problem focused exam of visual system | 212 | $17,585 | $66 |
| Removal of growth of eyelid | 61 | $15,143 | $229 |
| New patient visit (30+ min) | 135 | $10,800 | $80 |
| Face injection for nerve paralysis | 33 | $8,974 | $115 |
| Photography of content of eyes | 376 | $6,328 | $15 |
| Incision of tear duct using an endoscope | 11 | $5,433 | $494 |
| Exam of visual field with intermediate testing | 136 | $5,162 | $37 |
| Repair of brow paralysis | 14 | $4,417 | $315 |
| Suture repair of turning-outward upper or lower eyelid defect | 20 | $3,607 | $180 |
| Insertion of probe into nasal tear duct | 14 | $3,601 | $257 |
| Return visit (30+ min) | 30 | $2,762 | $77 |
| Suture repair of turning-inward eyelid defect | 19 | $2,644 | $139 |
| Removal of eyelashes using forceps | 34 | $2,255 | $38 |
| Removal of eyelashes | 17 | $1,900 | $100 |
| Exam of visual field with limited testing | 48 | $1,341 | $28 |
| Established patient complete exam of visual system | 12 | $1,233 | $103 |
| Probing of nasal tear duct with insertion of tube or stent | 11 | $1,171 | $106 |
| Snip incision of tear duct at inner corner of eye | 20 | $1,139 | $57 |
2014: 28 services
| Removal of excessive skin and fat of upper eyelid | 97 | $64,517 | $665 |
| Repair of tendon of upper eyelid | 64 | $43,819 | $674 |
| Insertion of probe into nasal tear duct | 103 | $30,664 | $253 |
| Established patient problem focused exam of visual system | 281 | $24,279 | $66 |
| Reconstruction of eyelid margin | 63 | $20,752 | $324 |
| Short return visit (20+ min) | 325 | $20,434 | $54 |
| Botox | 31 | $17,418 | None |
| Muscle flap wound repair at head and neck | 17 | $15,653 | $870 |
| Removal of growth of eyelid | 53 | $12,803 | $242 |
| Dilation of tear drainage opening | 63 | $10,154 | $118 |
| Face injection for nerve paralysis | 31 | $8,322 | $114 |
| New patient visit (30+ min) | 107 | $8,137 | $76 |
| Photography of content of eyes | 412 | $7,553 | $16 |
| Incision of tear duct using an endoscope | 13 | $7,184 | $513 |
| Repair of brow paralysis | 19 | $5,846 | $308 |
| Exam of visual field with intermediate testing | 121 | $4,570 | $37 |
| Return visit (30+ min) | 34 | $3,856 | $84 |
| Suture repair of turning-outward upper or lower eyelid defect | 19 | $3,266 | $172 |
| Removal of eyelashes using forceps | 46 | $2,661 | $42 |
| Removal of eyelashes | 20 | $2,277 | $103 |
| Suture repair of turning-inward eyelid defect | 15 | $2,173 | $136 |
| Closure of tear duct opening using plug | 11 | $2,016 | $144 |
| Established patient complete exam of visual system | 19 | $1,967 | $98 |
| Probing of nasal tear duct with insertion of tube or stent | 13 | $1,531 | $109 |
| New patient visit (45+ min) | 11 | $1,365 | $124 |
| Snip incision of tear duct at inner corner of eye | 13 | $1,245 | $96 |
| Exam of visual field with limited testing | 44 | $1,102 | $25 |
| Snip incision of tear duct at inner corner of eye | 17 | $908 | $53 |
2013: 29 services
| Removal of excessive skin and fat of upper eyelid | 114 | $77,017 | $653 |
| Repair of tendon of upper eyelid | 63 | $43,698 | $683 |
| Short return visit (20+ min) | 431 | $29,448 | $57 |
| Dilation of tear drainage opening | 139 | $24,688 | $123 |
| Reconstruction of eyelid margin | 68 | $24,266 | $357 |
| Established patient problem focused exam of visual system | 289 | $23,820 | $66 |
| Removal of growth of eyelid | 75 | $19,068 | $238 |
| Muscle flap wound repair at head and neck | 16 | $15,302 | $850 |
| Botox | 25 | $12,556 | None |
| New patient visit (30+ min) | 115 | $9,648 | $84 |
| Repair of defect of sclera with graft | 11 | $7,605 | $691 |
| Exam of visual field with intermediate testing | 168 | $6,817 | $39 |
| Photography of content of eyes | 336 | $5,853 | $16 |
| Face injection for nerve paralysis | 24 | $5,543 | $115 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 11 | $4,973 | $452 |
| Return visit (30+ min) | 42 | $4,008 | $82 |
| Suture repair of turning-outward upper or lower eyelid defect | 24 | $3,780 | $158 |
| Removal of eyelashes | 20 | $3,488 | $120 |
| Removal of eye contents with insertion of implant | 11 | $3,094 | $281 |
| Removal of eyelashes using forceps | 32 | $2,988 | $47 |
| Closure of tear duct opening using plug | 12 | $2,219 | $139 |
| Removal of chronic growth of eyelid | 13 | $1,676 | $105 |
| Suture repair of turning-inward eyelid defect | 13 | $1,613 | $124 |
| Snip incision of tear duct at inner corner of eye | 24 | $1,397 | $56 |
| New patient complete exam of visual system | 13 | $1,391 | $107 |
| Established patient complete exam of visual system | 12 | $1,196 | $80 |
| Exam of visual field with extended testing | 14 | $1,007 | $50 |
| Temporary closure of eyelids by suture | 15 | $613 | $41 |
| Exam of visual field with limited testing | 16 | $431 | $27 |
Medicaid work
$13,155 in 2024
Medicaid paid $13,155 for 129 billed services this clinician did in 2024, up to 32 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 65 | $9,172 |
| Return visit (30+ min) | 37 | $2,067 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 13 | $1,772 |
| Short return visit (20+ min) | 14 | $144 |
| 2024 | 129 | 4 | 32 | $13,155 |
| 2023 | 100 | 3 | 20 | $591 |
| 2022 | 39 | 3 | 13 | $140 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 74 | $473 |
| Return visit (30+ min) | 13 | $119 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 13 | $0 |
2022
| Short return visit (20+ min) | 13 | $98 |
| Fentanyl citrate injection | 13 | $22 |
| Injection, midazolam hydrochloride, per 1 mg | 13 | $20 |
Drugs they prescribed that Part D paid
$251,265
Pharmacies billed $251,265 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 15% of their Part D prescriptions (272 of 1,864) in 2024. A higher opioid share than 9 in 10 peers; the typical ophthalmology clinician is at 0%.
1,682 generic and fewer than 11 brand-name prescriptions · $251,265 in drug cost · 460 antibiotic prescriptions to 394 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tobramycin-Dexamethasone | 166 | $7,317 | $35 |
| Erythromycin | 438 | $5,869 | $10 |
| Neomycin-Polymyxin-Dexameth | 89 | $1,251 | $12 |
| Cephalexin | 247 | $1,072 | $4 |
| Moxifloxacin | 11 | $829 | $44 |
See all 17 drugs
| Tobramycin-Dexamethasone | 166 | $7,317 | $35 |
| Erythromycin | 438 | $5,869 | $10 |
| Neomycin-Polymyxin-Dexameth | 89 | $1,251 | $12 |
| Cephalexin | 247 | $1,072 | $4 |
| Moxifloxacin | 11 | $829 | $44 |
| Prednisolone Acetate | 13 | $727 | $36 |
| Amoxicillin-Clavulanate Potass | 56 | $471 | $8 |
| Tramadol | 210 | $437 | $2 |
| Clindamycin | 19 | $403 | $15 |
| Hydrocodone-Acetaminophen | 52 | $333 | $6 |
| Methylprednisolone | 41 | $264 | $6 |
| Sulfamethoxazole-Trimethoprim | 71 | $228 | $3 |
| Mupirocin | 21 | $149 | $7 |
| Levofloxacin | 16 | $75 | $5 |
| Azithromycin | 14 | $63 | $3 |
| Lorazepam | 18 | $25 | $1 |
| Promethazine | 11 | $21 | $2 |
Year by year
| 2024 | 1,864 | 655 | 15% (272) | None | $251,265 |
| 2023 | 1,861 | 508 | 19% (344) | 10% | $647,127 |
| 2022 | 1,681 | 431 | 13% (216) | 11% | $43,465 |
| 2021 | 1,332 | 388 | 13% (175) | 13% | $45,361 |
| 2020 | 1,401 | 397 | 14% (202) | 14% | $46,076 |
| 2019 | 1,695 | 404 | 13% (221) | 15% | $62,126 |
| 2018 | 1,311 | 375 | 16% (204) | 18% | $61,733 |
| 2017 | 1,376 | 413 | 15% (208) | 20% | $70,055 |
| 2016 | 1,354 | 385 | 15% (199) | 25% | $77,162 |
| 2015 | 1,315 | 389 | 16% (214) | 35% | $82,197 |
| 2014 | 1,480 | 407 | 15% (216) | 32% | $82,056 |
| 2013 | 1,137 | 368 | 17% (194) | 38% | $69,743 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Tepezza | 12 | $604,645 | $50,387 |
| Tobramycin-Dexamethasone | 209 | $13,497 | $65 |
| Erythromycin | 448 | $4,872 | $11 |
| Cephalexin | 329 | $3,044 | $9 |
| Tobradex | 11 | $2,306 | $210 |
| Neomycin-Polymyxin-Dexameth | 83 | $1,320 | $16 |
| Tramadol | 308 | $1,059 | $3 |
| Betamethasone Diprop Augmented | 16 | $811 | $51 |
| Moxifloxacin | 14 | $600 | $43 |
| Methylprednisolone | 44 | $488 | $11 |
| Clindamycin | 33 | $427 | $13 |
| Prednisolone Acetate | 12 | $378 | $31 |
| Mupirocin | 41 | $368 | $9 |
| Sulfamethoxazole-Trimethoprim | 58 | $323 | $6 |
| Fluticasone Propionate | 19 | $318 | $17 |
| Hydrocodone-Acetaminophen | 34 | $284 | $8 |
| Valacyclovir | 25 | $236 | $9 |
| Azithromycin | 17 | $205 | $12 |
| Fluconazole | 11 | $91 | $8 |
| Tobramycin | 15 | $84 | $6 |
| Promethazine | 17 | $44 | $3 |
2022: 21 drugs
| Tobramycin-Dexamethasone | 176 | $12,849 | $73 |
| Erythromycin | 367 | $3,929 | $11 |
| Cephalexin | 262 | $2,333 | $9 |
| Flarex | 13 | $2,033 | $156 |
| Neomycin-Polymyxin-Dexameth | 107 | $1,791 | $17 |
| Methylprednisolone | 102 | $923 | $9 |
| Betamethasone Diprop Augmented | 16 | $758 | $47 |
| Prednisolone Acetate | 19 | $739 | $39 |
| Valacyclovir | 59 | $676 | $11 |
| Azelastine | 14 | $623 | $45 |
| Tramadol | 149 | $491 | $3 |
| Hydrocodone-Acetaminophen | 63 | $428 | $7 |
| Clindamycin | 33 | $391 | $12 |
| Sulfamethoxazole-Trimethoprim | 64 | $355 | $6 |
| Gentamicin Sulfate | 32 | $337 | $11 |
| Fluconazole | 19 | $187 | $10 |
| Mupirocin | 20 | $156 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $93 | $8 |
| Levofloxacin | 12 | $53 | $4 |
| Ibuprofen | 14 | $40 | $3 |
| Promethazine | 14 | $39 | $3 |
2021: 13 drugs
| Tobramycin-Dexamethasone | 125 | $10,383 | $83 |
| Erythromycin | 336 | $4,166 | $12 |
| Cephalexin | 226 | $1,730 | $8 |
| Neomycin-Polymyxin-Dexameth | 65 | $1,049 | $16 |
| Azelastine | 23 | $853 | $37 |
| Betamethasone Diprop Augmented | 16 | $710 | $44 |
| Hydrocodone-Acetaminophen | 98 | $692 | $7 |
| Methylprednisolone | 55 | $576 | $10 |
| Clindamycin | 33 | $414 | $13 |
| Gentamicin Sulfate | 32 | $272 | $8 |
| Mupirocin | 31 | $245 | $8 |
| Tramadol | 71 | $209 | $3 |
| Sulfamethoxazole-Trimethoprim | 45 | $192 | $4 |
2020: 18 drugs
| Tobramycin-Dexamethasone | 135 | $11,715 | $87 |
| Erythromycin | 333 | $4,182 | $13 |
| Olopatadine | 28 | $2,659 | $95 |
| Cephalexin | 267 | $1,660 | $6 |
| Hydrocodone-Acetaminophen | 158 | $1,049 | $7 |
| Neomycin-Polymyxin-Dexameth | 52 | $874 | $17 |
| Azithromycin | 12 | $650 | $54 |
| Ketorolac Tromethamine | 11 | $602 | $55 |
| Methylprednisolone | 45 | $495 | $11 |
| Fluticasone Propionate | 18 | $328 | $18 |
| Valacyclovir | 18 | $310 | $17 |
| Clindamycin | 31 | $300 | $10 |
| Mupirocin | 35 | $258 | $7 |
| Sulfamethoxazole-Trimethoprim | 40 | $196 | $5 |
| Prednisone | 12 | $181 | $15 |
| Gentamicin Sulfate | 15 | $88 | $6 |
| Tramadol | 33 | $86 | $3 |
| Levofloxacin | 13 | $59 | $5 |
2019: 19 drugs
| Tobramycin-Dexamethasone | 197 | $17,646 | $90 |
| Erythromycin | 366 | $4,631 | $13 |
| Olopatadine | 52 | $4,438 | $85 |
| Lotemax | 18 | $4,347 | $242 |
| Bacitracin | 25 | $2,284 | $91 |
| Cephalexin | 288 | $2,178 | $8 |
| Hydrocodone-Acetaminophen | 177 | $1,120 | $6 |
| Azelastine | 24 | $1,102 | $46 |
| Methylprednisolone | 86 | $1,072 | $12 |
| Neomycin-Polymyxin-Dexameth | 65 | $889 | $14 |
| Ketorolac Tromethamine | 15 | $771 | $51 |
| Clindamycin | 60 | $743 | $12 |
| Mupirocin | 40 | $348 | $9 |
| Sulfamethoxazole-Trimethoprim | 44 | $270 | $6 |
| Fluticasone Propionate | 22 | $270 | $12 |
| Gentamicin Sulfate | 19 | $200 | $11 |
| Tramadol | 33 | $85 | $3 |
| Promethazine | 16 | $48 | $3 |
| Diazepam | 25 | $22 | $1 |
2018: 19 drugs
| Tobramycin-Dexamethasone | 143 | $12,304 | $86 |
| Olopatadine | 67 | $6,637 | $99 |
| Pazeo | 25 | $5,892 | $236 |
| Lotemax | 16 | $3,957 | $247 |
| Erythromycin | 321 | $3,274 | $10 |
| Cephalexin | 155 | $1,289 | $8 |
| Hydrocodone-Acetaminophen | 171 | $1,174 | $7 |
| Fluorometholone | 13 | $1,076 | $83 |
| Neomycin-Polymyxin-Dexameth | 72 | $1,042 | $14 |
| Fluticasone Propionate | 41 | $677 | $17 |
| Methylprednisolone | 46 | $629 | $14 |
| Clindamycin | 23 | $306 | $13 |
| Mupirocin | 19 | $213 | $11 |
| Ofloxacin | 12 | $207 | $17 |
| Sulfamethoxazole-Trimethoprim | 29 | $185 | $6 |
| Gentamicin Sulfate | 11 | $147 | $13 |
| Levofloxacin | 13 | $116 | $9 |
| Acetaminophen-Codeine | 12 | $75 | $6 |
| Tramadol | 19 | $59 | $3 |
2017: 23 drugs
| Tobramycin-Dexamethasone | 178 | $16,080 | $90 |
| Pataday | 65 | $11,540 | $178 |
| Pazeo | 35 | $8,405 | $240 |
| Lotemax | 21 | $5,240 | $250 |
| Olopatadine | 30 | $3,550 | $118 |
| Erythromycin | 320 | $3,403 | $11 |
| Bacitracin | 16 | $1,592 | $100 |
| Hydrocodone-Acetaminophen | 173 | $1,037 | $6 |
| Methylprednisolone | 48 | $752 | $16 |
| Cephalexin | 117 | $713 | $6 |
| Neomycin-Polymyxin-Dexameth | 33 | $636 | $19 |
| Fluticasone Propionate | 38 | $572 | $15 |
| Ofloxacin | 20 | $464 | $23 |
| Clindamycin | 31 | $412 | $13 |
| Latanoprost | 17 | $283 | $17 |
| Gentamicin Sulfate | 22 | $250 | $11 |
| Mupirocin | 24 | $223 | $9 |
| Sulfamethoxazole-Trimethoprim | 32 | $175 | $5 |
| Levofloxacin | 11 | $174 | $16 |
| Valacyclovir | 11 | $120 | $11 |
| Tramadol | 24 | $70 | $3 |
| Acetaminophen-Codeine | 11 | $53 | $5 |
| Promethazine | 12 | $43 | $4 |
2016: 16 drugs
| Pataday | 98 | $15,744 | $161 |
| Tobramycin-Dexamethasone | 177 | $14,723 | $83 |
| Restasis | 11 | $12,784 | $1,162 |
| Pazeo | 40 | $10,394 | $260 |
| Erythromycin | 322 | $3,776 | $12 |
| Lotemax | 13 | $2,678 | $206 |
| Hydrocodone-Acetaminophen | 186 | $1,490 | $8 |
| Neomycin-Polymyxin-Dexameth | 50 | $964 | $19 |
| Cephalexin | 131 | $931 | $7 |
| Methylprednisolone | 43 | $732 | $17 |
| Mupirocin | 28 | $338 | $12 |
| Fluticasone Propionate | 20 | $273 | $14 |
| Sulfamethoxazole-Trimethoprim | 41 | $239 | $6 |
| Gentamicin Sulfate | 21 | $223 | $11 |
| Levofloxacin | 14 | $188 | $13 |
| Promethazine | 11 | $44 | $4 |
2015: 18 drugs
| Pataday | 122 | $19,124 | $157 |
| Tobramycin-Dexamethasone | 159 | $13,123 | $83 |
| Lotemax | 24 | $5,288 | $220 |
| Bacitracin | 60 | $4,557 | $76 |
| Alrex | 17 | $3,899 | $229 |
| Neomycin-Polymyxin-Dexameth | 202 | $3,617 | $18 |
| Pazeo | 14 | $2,122 | $152 |
| Erythromycin | 152 | $1,974 | $13 |
| Lumigan | 11 | $1,468 | $133 |
| Hydrocodone-Acetaminophen | 178 | $1,443 | $8 |
| Fluorometholone | 14 | $1,028 | $73 |
| Methylprednisolone | 34 | $719 | $21 |
| Cephalexin | 76 | $572 | $8 |
| Ofloxacin | 14 | $192 | $14 |
| Sulfamethoxazole-Trimethoprim | 26 | $166 | $6 |
| Latanoprost | 13 | $136 | $10 |
| Acetaminophen-Codeine | 17 | $117 | $7 |
| Tramadol | 19 | $65 | $3 |
2014: 22 drugs
| Tobramycin-Dexamethasone | 142 | $13,394 | $94 |
| Pataday | 83 | $12,021 | $145 |
| Tobradex | 52 | $9,413 | $181 |
| Alrex | 33 | $6,817 | $207 |
| Neomycin-Polymyxin-Dexameth | 294 | $5,552 | $19 |
| Lotemax | 20 | $3,572 | $179 |
| Zylet | 14 | $3,109 | $222 |
| Erythromycin | 154 | $2,323 | $15 |
| Azasite | 14 | $2,113 | $151 |
| Doxycycline Hyclate | 13 | $2,068 | $159 |
| Hydrocodone-Acetaminophen | 175 | $1,768 | $10 |
| Prednisolone Acetate | 19 | $1,075 | $57 |
| Methylprednisolone | 39 | $908 | $23 |
| Cephalexin | 96 | $812 | $8 |
| Levofloxacin | 25 | $486 | $19 |
| Gentamicin Sulfate | 39 | $394 | $10 |
| Sulfamethoxazole-Trimethoprim | 43 | $259 | $6 |
| Mupirocin | 14 | $220 | $16 |
| Ofloxacin | 11 | $145 | $13 |
| Tramadol | 20 | $95 | $5 |
| Acetaminophen-Codeine | 12 | $85 | $7 |
| Promethazine | 18 | $69 | $4 |
2013: 12 drugs
| Tobradex | 109 | $18,165 | $167 |
| Pataday | 92 | $11,623 | $126 |
| Tobramycin-Dexamethasone | 104 | $10,664 | $103 |
| Lotemax | 23 | $3,514 | $153 |
| Neomycin-Polymyxin-Dexameth | 188 | $3,351 | $18 |
| Erythromycin | 123 | $1,882 | $15 |
| Doxycycline Hyclate | 12 | $1,739 | $145 |
| Hydrocodone-Acetaminophen | 182 | $780 | $4 |
| Cephalexin | 80 | $642 | $8 |
| Methylprednisolone | 22 | $524 | $24 |
| Fluorometholone | 13 | $159 | $12 |
| Sulfamethoxazole-Trimethoprim | 18 | $121 | $7 |
Money from drug and device companies
$403 in 2025
| 2025 | 3 | 7 | None | $403 |
| 2024 | 2 | 14 | None | $233 |
| 2023 | 4 | 34 | None | $4,161 |
| 2022 | 6 | 38 | None | $2,136 |
| 2021 | 6 | 12 | None | $498 |
| 2020 | 3 | 3 | None | $56 |
| 2019 | 5 | 21 | None | $845 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tepezza | $225 | 5 payments
|
| Alcon Vision | None | $147 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea Hd | $31 | 1 payment
|
See all 7 published payments
| Alcon Vision | Meals · 2025-11-12 | None | $147 |
| Amgen | Meals · 2025-08-21 | Tepezza | $14 |
| Amgen | Meals · 2025-06-17 | Tepezza | $10 |
| Amgen | Meals · 2025-05-13 | Tepezza | $13 |
| Amgen | Meals · 2025-05-13 | Tepezza | $168 |
| Amgen | Meals · 2025-02-27 | Tepezza | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-02-13 | Eylea Hd | $31 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $233
| Amgen | Tepezza | $213 | 13 payments
|
| RxSight | Rxsight Contact Lens | $20 | 1 payment
|
2023: $4,161
| Merz North America | Xeomin | $3,957 | 16 payments
|
| Horizon Therapeutics plc | Tepezza | $169 | 16 payments
|
| Eyevance Pharmaceuticals | Tobradex St | $20 | 1 payment
|
| Galderma Laboratories L.P. | None | $14 | 1 payment
|
2022: $2,136
| Merz North America | None | $1,787 | 11 payments
|
| Horizon Therapeutics plc | Tepezza | $144 | 17 payments
|
| Allergan | Botox | $83 | 4 payments
|
| Merz Pharmaceuticals | Xeomin | $51 | 2 payments
|
| Galderma Laboratories L.P. | None | $48 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $25 | 1 payment
|
2021: $498
| Merz North America | None | $347 | 4 payments
|
| Galderma Laboratories L.P. | None | $44 | 3 payments
|
| Allergan | None | $38 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $25 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $23 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $22 | 1 payment
|
2020: $56
| Sun Pharmaceutical Industries | Cequa | $20 | 1 payment
|
| Galderma Laboratories L.P. | None | $20 | 1 payment
|
| Allergan | None | $16 | 1 payment
|
2019: $845
| Merz North America | Xeomin | $531 | 8 payments
|
| Galderma Laboratories L.P. | None | $194 | 9 payments
|
| TissueTech | Prokera | $80 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Zylet | $24 | 1 payment
|
| Allergan | None | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689693657
- Licence
- CA A86968California A86968: Current · expires 2028-05-31
- Trained
- George Washington University School of Medicine, 1999 · 27 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A869680
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1360 E Herndon Avenue, Suite 301, Fresno, CA, 93720
- NPI first listed
- 2006-07-19
- NPI last updated
- 2020-09-29
- NPI record certified
- 2020-09-29
This is when the NPI record was last certified, not a medical board exam.